Do not share your Fiasp® with other people, even if the needle has been changed. You may give other people a serious infection or get a serious infection from them.
Fiasp®—with the first bitea
Fiasp® is an injectable prescription medication used to help improve blood sugar in adults with type 1 and type 2 diabetes.
At its core, Fiasp®:
- Is designed to start working fast
- Enters the bloodstream in approximately 2 ½ minutes
- Gives you options for when you can take it: at the start of a meal or up to 20 minutes after starting a meal
- Is proven to help lower A1C when taken with a long-acting insulin
Savings and personalized support are available
Novo Nordisk offers the same co-pay for Fiasp® as NovoLog® (insulin aspart injection) 100 U/mL.
Check to see if you’re covered, and find your Fiasp® co-pay ›
Join Cornerstones4Care® for free support that will help you get started with your new medication and 4 cornerstones of diabetes care: healthy eating, being active, medicine, and tracking.
Race with Insulin®
Charlie Kimball is the first licensed INDYCAR driver with type 1 diabetes. Charlie knows that it takes a lot to compete at the highest levels of racing. He prepares for his races by eating right, exercising, and using Fiasp® as part of his diabetes care plan—a mealtime insulin that is designed to start working fast.